scispace - formally typeset
M

Marcello Pinti

Researcher at University of Modena and Reggio Emilia

Publications -  185
Citations -  13448

Marcello Pinti is an academic researcher from University of Modena and Reggio Emilia. The author has contributed to research in topics: Mitochondrion & Immune system. The author has an hindex of 46, co-authored 163 publications receiving 11592 citations. Previous affiliations of Marcello Pinti include University of Milan & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Long COVID: A New Challenge for Prevention of Obesity in Women

TL;DR: The present commentary explores the relationship between long COVID and obesity in women and finds that during the pandemic, various factors contributed greatly to aggravating Obesity in women leading to a pro-inflammatory and prothrombotic status.
Journal ArticleDOI

Cardiovascular prevention in women: an update by the Italian Society of Cardiology working group on 'Prevention, hypertension and peripheral disease'.

TL;DR: In this paper , the authors focus on the new approach to cardiovascular prevention in women in light of the lifestyle changes recorded during the pandemic and which led to an increase in obesity examines the effects on the cardiovascular system induced by stress and depression and analyses the new high blood pressure guidelines and indications that are specific to women.
Journal ArticleDOI

Mitochondrial and Endoplasmic Reticulum Alterations in a Case of Amyotrophic Lateral Sclerosis Caused by TDP-43 A382T Mutation

TL;DR: In this article , the authors report the clinical and biological features of an ALS patients with pA382T mutation in TPD-43 protein, which impacts particularly the mitochondrial metabolic pathways and the endoplasmic reticulum.
Journal ArticleDOI

The importance of advanced cytometry in defining new immune cell types and functions relevant for the immunopathogenesis of HIV infection.

TL;DR: Advanced technologies based upon the simultaneous detection of HIV-RNA and proteins at the single cell level, as well as those based upon spectral cytometry or mass cytometry are now finding new actors and depicting a new scenario in the immunopathogenesis of the infection, that will allow to better design innovative therapies based upon novel drugs and vaccines.